Abstract: A process for stabilizing a macerated oil, the macerated oil including a liquid carrier and a compound soluble in said liquid carrier, the compound containing at least one cannabinoid. The process removes oxygen from the liquid carrier before, during or after the dissolution of the soluble compound. The process includes a step of introducing the liquid carrier into a containment device and, subsequently, removing oxygen by creating a vacuum lower than 400 mbar inside the containment device until the oxygen present both in the containment device and inside the liquid carrier is removed.
Abstract: A composition comprising a blend of at least two standardized extracts in their active components coming from a stable variety of Cannabis sativa L., for use in the treatment of an inflammatory bowel disease and/or in the prevention of bowel diseases correlated to acute, chronic inflammation and dysbiosis, said standardized extracts comprising in their active components cannabigerol and cannabidiol in various mass ratios.
Type:
Application
Filed:
May 13, 2024
Publication date:
June 11, 2026
Applicant:
LINNEA SA
Inventors:
Nora ROSSINI, Umberto CIRIELLO, Mario DELL'AGLI, Valeria DE BONA, Giulia MARTINELLI, Giuseppe PALADINO, Stefano PIAZZA, Enrico SANGIOVANNI
Abstract: A composition of a Cannabis sativa extract comprising cannabinoids in concentrations ranging from 0.500 to 10.000% (w/w), and terpenes in concentrations ranging from 0.005 to 1.000% (w/w). The use of the composition in the prevention and/or treatment of inflammatory diseases is also described. The composition may also be used as a functional food ingredient.
Type:
Application
Filed:
July 13, 2021
Publication date:
August 3, 2023
Applicant:
LINNEA SA
Inventors:
Nora ROSSINI, Mario DELL'AGLI, Marcello LUZZANI, Giuseppe PALADINO, Umberto CIRIELLO, Enrico SANGIOVANNI, Stefano PIAZZA, Selina RUSCONI
Abstract: The present invention relates to a topical composition comprising plant extracts. In particular, the present invention relates to a topical composition comprising plant extracts embedded in hydrophilic vesicles (niosomes), preferably having a size smaller than 500 nm, and at least one topically acceptable excipient.
Abstract: A process for extracting isoflavones from a plant material, wherein the said process comprises treating the plant material with an organic solvent, characterized in that the said extraction is preceded by a step of maceration in water. A dry extract containing, as aglycones, at least 8% (w/w) of one or more isoflavones or formula
wherein
R1=OH and R2=H, Genistein;
R1=H and R2=H, Daidzein;
R1=H and R2=CH3, Formononetin;
R1=OH and R2=CH3, Biochanin A.
Abstract: A water-soluble complex of N-methylglucamine with an extract of Ginkgo biloba leaves, process for the preparation thereof and composition comprising the same.
Abstract: A process for extracting isoflavones from a plant material, wherein the said process comprises treating the plant material with an organic solvent, characterized in that the said extraction is preceded by a step of maceration in water.
Abstract: A water-soluble complex of N-methylglucamine with an extract of Ginkgo biloba leaves, process for the preparation thereof and composition comprising the same.